SUPPLEMENT AGREEMENTSupplement Agreement • March 23rd, 2018 • HTG Molecular Diagnostics, Inc • Laboratory analytical instruments • Delaware
THIS SUPPLEMENT AGREEMENT (this “Supplement Agreement”) is effective June 2, 2017 (the “Effective Date”) and is made and entered into by and between HTG Molecular Diagnostics, Inc., having a place of business at 3430 E. Global Loop, Tucson, AZ 85706, U.S.A. (“HTG”), QIAGEN Manchester Limited, having a place of business at Skelton House, Lloyd Street North, Manchester, M15 6SH, England (“QIAGEN”), and Bristol-Myers Squibb Company, having a place of business at Route 206 & Province Line Road, Princeton, NJ 08543-4000, U.S.A. (“BMS”). QIAGEN, HTG and BMS are collectively referred to as the “Parties,” and each individually as a “Party.”
